Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 1
2008 1
2010 1
2011 1
2013 1
2014 3
2015 1
2016 2
2017 6
2018 4
2019 2
2020 2
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Oncogenic signaling of MEK5-ERK5.
Hoang VT, Yan TJ, Cavanaugh JE, Flaherty PT, Beckman BS, Burow ME. Hoang VT, et al. Among authors: cavanaugh je. Cancer Lett. 2017 Apr 28;392:51-59. doi: 10.1016/j.canlet.2017.01.034. Epub 2017 Jan 30. Cancer Lett. 2017. PMID: 28153789 Free PMC article. Review.
Duloxetine pharmacology: profile of a dual monoamine modulator.
Karpa KD, Cavanaugh JE, Lakoski JM. Karpa KD, et al. Among authors: cavanaugh je. CNS Drug Rev. 2002 Winter;8(4):361-76. doi: 10.1111/j.1527-3458.2002.tb00234.x. CNS Drug Rev. 2002. PMID: 12481192 Free PMC article. Review.
Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
Matossian MD, Hoang VT, Burks HE, La J, Elliott S, Brock C, Rusch DB, Buechlein A, Nephew KP, Bhatt A, Cavanaugh JE, Flaherty PT, Collins-Burow BM, Burow ME. Matossian MD, et al. Among authors: cavanaugh je. Oncoscience. 2021 May 18;8:64-71. doi: 10.18632/oncoscience.535. eCollection 2021. Oncoscience. 2021. PMID: 34026925 Free PMC article.
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
Hoang VT, Matossian MD, La J, Hoang K, Ucar DA, Elliott S, Burks HE, Wright TD, Patel S, Bhatt A, Phamduy T, Chrisey D, Buechlein A, Rusch DB, Nephew KP, Anbalagan M, Rowan B, Cavanaugh JE, Flaherty PT, Miele L, Collins-Burow BM, Burow ME. Hoang VT, et al. Among authors: cavanaugh je. J Cell Biochem. 2021 Aug;122(8):835-850. doi: 10.1002/jcb.29916. Epub 2021 Apr 20. J Cell Biochem. 2021. PMID: 33876843
28 results